AMARIN CORPORATION PLC

NASDAQ: AMRN (Amarin Corporation plc)

Kemas kini terakhir: 8 jam lalu

11.59

-0.09 (-0.77%)

Penutupan Terdahulu 11.68
Buka 11.56
Jumlah Dagangan 50,431
Purata Dagangan (3B) 99,683
Modal Pasaran 239,994,128
Harga / Jualan (P/S) 0.930
Harga / Buku (P/B) 0.440
Julat 52 Minggu
7.00 (-39%) — 17.60 (51%)
Tarikh Pendapatan 6 Aug 2025
Margin Keuntungan -35.95%
Margin Operasi (TTM) -25.76%
EPS Cair (TTM) -4.00
Pertumbuhan Hasil Suku Tahunan (YOY) -16.60%
Jumlah Hutang/Ekuiti (D/E MRQ) 1.99%
Nisbah Semasa (MRQ) 3.31
Aliran Tunai Operasi (OCF TTM) -31.02 M
Aliran Tunai Bebas Leveraj (LFCF TTM) 8.00 M
Pulangan Atas Aset (ROA TTM) -4.56%
Pulangan Atas Ekuiti (ROE TTM) -15.83%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Drug Manufacturers - General (US) Menurun Bercampur
Drug Manufacturers - General (Global) Menurun Bercampur
Stok Amarin Corporation plc Menaik Menaik

AISkor Stockmoo

-0.4
Konsensus Penganalisis -1.5
Aktiviti Orang Dalam NA
Volatiliti Harga -2.0
Purata Bergerak Teknikal 0.0
Osilator Teknikal 2.0
Purata -0.38

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
AMRN 240 M - - 0.440
MIRA 23 M - - 7.95
SCLXW - - - -
AZN 220 B 2.20% 28.38 6.19
SNY 127 B 8.05% 20.32 1.61
AMGN 143 B 3.48% 24.26 24.96

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Sektor Healthcare
Industri Drug Manufacturers - General
% Dimiliki oleh Orang Dalam 1.76%
% Dimiliki oleh Institusi 20.91%

Pemilikan

Nama Tarikh Syer Dipegang
Waterfront Wealth Inc. 31 Mar 2025 125,731
Scp Investment, Lp 31 Mar 2025 125,000
Kornitzer Capital Management Inc /Ks 31 Mar 2025 88,200
Longitude (Cayman) Ltd. 31 Dec 2024 81,000
Hayek Kallen Investment Management 31 Mar 2025 51,216
18.0518.0513.4013.408.758.754.104.10-0.550-0.550Harga Sasaran MedianQ3 '20Q3 '20Q4 '20Q4 '20Q1 '21Q1 '21Q2 '21Q2 '21Q3 '21Q3 '21Q4 '21Q4 '21Q1 '22Q1 '22Q2 '22Q2 '22Q3 '22Q3 '22Q4 '22Q4 '22Q1 '23Q1 '23Q2 '23Q2 '23Q3 '23Q3 '23Q4 '23Q4 '23Q1 '24Q1 '24Q2 '24Q2 '24Q3 '24Q3 '24Q4 '24Q4 '24Q1 '25Q1 '25Q2 '25Q2 '25
Julat 52 Minggu
7.00 (-39%) — 17.60 (51%)
Median 7.00 (-39.60%)
Jumlah 1 Jual
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
Goldman Sachs 17 Apr 2025 7.00 (-39.60%) Jual 9.11

Tiada data dalam julat masa ini.

Tarikh Jenis Butiran
07 May 2025 Pengumuman Amarin Reports First Quarter 2025 Financial Results
29 Apr 2025 Pengumuman Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement
28 Apr 2025 Pengumuman Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025
09 Apr 2025 Pengumuman Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change
07 Apr 2025 Pengumuman Amarin Appoints JEC Capital Partners’ Michael Torok to Board of Directors
31 Mar 2025 Pengumuman Amarin Highlights Recent Data Presented at ACC.25 Evaluating Mechanistic Effects of Eicosapentaenoic Acid (EPA) in Lp(a)-Enriched Plasma and in Combination with GLP-1 Agonist
28 Mar 2025 Pengumuman National Triglyceride Alliance Launches to Advance Clinician Education on High Triglycerides and the Importance of Proactive Triglyceride Management
19 Mar 2025 Pengumuman New Research Exploring Mechanistic Benefits of Eicosapentaenoic Acid (EPA) In Vitro on Lipoprotein(a) [Lp(a)] Oxidation and on Protein Expression in Endothelial Cells in Combination with GLP-1 Receptor Agonist to be Presented at the American College o...
19 Mar 2025 Pengumuman Concerned Shareholder Group Urges Amarin’s Board of Directors to Initiate a Strategic Review Following Two Years of Underperformance
12 Mar 2025 Pengumuman Amarin Announces Plan to Initiate a Ratio Change Under Its American Depository Receipt (ADR) Program
12 Mar 2025 Pengumuman Amarin Reports Fourth Quarter Financial Results & Business Update and Announces Important Corporate Action 
Papar semua
11.9911.9911.4011.4010.8110.8110.2310.239.649.64May 20May 20May 21May 21May 22May 22May 23May 23May 27May 27May 28May 28May 29May 29May 30May 30

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

10010075755050252500RSI (14H)
0.8000.8000.6000.6000.4000.4000.2000.2000.0000.000MACD (12, 26, 9)

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda